Manganese superoxide dismutase expression is negatively associated with microRNA-301a in human pancreatic ductal adenocarcinoma

Cancer Gene Therapy

Volumn 22, Issue 10, 2015, Pages 481-486

  Pandit, H ^a   Zhang, W ^b   Li, Y ^a,c   Agle, S ^a   Li, X ^a   Li, S P ^a   Cui, G ^a   Martin, R C G ^a  

^a University of Louisville School of Medicine   (United States)

^b JILIN UNIVERSITY   (China)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MANGANESE SUPEROXIDE DISMUTASE; MICRORNA; MICRORNA 301A; UNCLASSIFIED DRUG; MIRN301 MICRORNA, HUMAN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CANCER TISSUE; COMPUTER MODEL; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MOUSE MODEL; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PANCREATIC TISSUE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; NUDE MOUSE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; PANCREATIC NEOPLASMS; SUPEROXIDE DISMUTASE; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 84944512179     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2015.46     Document Type: Article

References (27)

1. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2012 Incidence and Mortality Web-based Report. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute: Atlanta; 2015. Available at: www.cdc.gov/uscs.
2. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse S et al. (eds). SEER Cancer Statistics Review, 1975-2010. Available at: http://seer.cancer.gov/csr/1975-2010/(2013) Last date accessed 5 July 2015.
3. Maitra A, Hruban RH. Pancreatic cancer. Ann Rev Pathol: Mechan Dis 3: 157-188.
4. Cullen JJ, Weydert C, Hinkhouse MM, Ritchie J, Domann FE, Spitz D et al. The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res 2003; 63: 1297-1303.
5. Holley AK, Dhar SK, Xu Y, St Clair DK. Manganese superoxide dismutase: beyond life and death. Amino Acids 2012; 42: 139-158.
6. Ough M, Lewis A, Zhang Y, Hinkhouse MM, Ritchie JM, Oberley LW et al. Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radic Res 2004; 38: 1223-1233.
7. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997; 275: 1649-1652.
8. Meng X, Wu J, Pan C, Wang H, Ying X, Zhou Y et al. Genetic and epigenetic downregulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Gastroenterology 2013; 145: 426-36, e1-e6.
9. Xu Y, Fang F, Zhang J, Josson S, St Clair WH, St Clair DK. miR-17 suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes. PLoS One 2010; 5: e14356.
10. Ji G, Lv K, Chen H, Wang T, Wang Y, Zhao D et al. MiR-146a regulates SOD2 expression in H2O2 stimulated PC12 cells. PLoS One 2013; 8: e69351.
11. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
12. Bushati N, Cohen SM. MicroRNA functions. Annu Rev Cell Dev Biol 2007; 23: 175-205.
13. Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010; 18: 510-525.
14. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441-450.
15. Qin S, Zhang C. MicroRNAs in vascular disease. J Cardiovasc Pharmacol 2011; 57: 8-12.
16. Lynam-Lennon N, Maher SG, Reynolds JV. The roles of microRNA in cancer and apoptosis. Biol Rev Cambridge Philos Soc 2009; 84: 55-71.
17. Zhang L, Jamaluddin MS, Weakley SM, Yao Q, Chen C. Roles and mechanisms of microRNAs in pancreatic cancer. World J Surg 2011; 35: 1725-1731.
18. Huang L, Liu Y, Wang L, Chen R, Ge W, Lin Z et al. Down-regulation of miR-301a suppresses pro-inflammatory cytokines in TLR-triggered macrophages. Immunology 2013; 140: 314-322.
19. Ma F, Zhang J, Zhong L, Wang L, Liu Y, Wang Y et al. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/beta-catenin signaling. Gene 2014; 535: 191-197.
20. Wang M, Li C, Yu B, Su L, Li J, Ju J et al. Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. J Gastroenterol 2013; 48: 1023-1033.
21. Xu XD, He XJ, Tao HQ, Zhang W, Wang YY, Ye ZY et al. Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis. J Surg Oncol 2013; 108: 197-202.
22. Zhou P, Jiang W, Wu L, Chang R, Wu K, Wang Z. miR-301a is a candidate oncogene that targets the homeobox gene Gax in human hepatocellular carcinoma. Digest Dis Sci 2012; 57: 1171-1180.
23. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 2007; 120: 1046-1054.
24. Chen Z, Chen LY, Dai HY, Wang P, Gao S, Wang K. miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression. J Cell Biochem 2012; 113: 3229-3235.
25. Lu Z, Li Y, Takwi A, Li B, Zhang J, Conklin DJ et al. miR-301a as an NF-kappaB activator in pancreatic cancer cells. EMBO J 2011; 30: 57-67.
26. Wang M, Li C, Yu B, Su L, Li J, Ju J et al. Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. J Gastroenterol 2013; 48: 1023-1033.
27. Huang L, Liu Y, Wang L, Chen R, Ge W, Lin Z et al. Down-regulation of miR-301a suppresses pro-inflammatory cytokines in Toll-like receptor-triggered macrophages. Immunology 2013; 140: 314-322.